SUPN - Supernus Pharmaceuticals Inc. (SUPN) CEO Jack Khattar on Q3 2021 Results - Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (SUPN) Q3 2021 Earnings Conference Call November 03, 2021 04:30 PM ET Company Participants Peter Vozzo - Westwicke, Investor Relations Jack Khattar - Chief Executive Officer Tim Dec - Chief Financial Officer Conference Call Participants David Steinberg - Jefferies Ken Cacciatore - Cowen David Amsellem - Piper Sandler Annabel Samimy - Stifel Presentation Operator Good afternoon, and welcome to Supernus Pharmaceuticals' Third Quarter 2021 Financial Results Conference Call [Operator Instructions]. As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of Westwicke Investor Relations representative for Supernus pharmaceuticals. You may begin. Peter Vozzo Thank you, Nika. Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals' Third Quarter 2021 Financial Results Conference Call. Today, after the close of the market, the company issued a press release announcing these results. On the call with
For further details see:
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2021 Results - Earnings Call Transcript